ComplicationsBy Mayo Clinic staff
Complications of prolactinoma may include:
- Vision loss. Left untreated, a prolactinoma may grow large enough to compress your optic nerve.
- Hypopituitarism. With larger prolactinomas, pressure on the normal pituitary gland can cause dysfunction of other hormones controlled by the pituitary, resulting in hypothyroidism, adrenal insufficiency and growth hormone deficiency.
- Bone loss (osteoporosis). Too much prolactin can reduce production of the hormones estrogen and testosterone, resulting in decreased bone density and an increased risk of osteoporosis.
Pregnancy complications. During a normal pregnancy, a woman's pituitary gland enlarges and prolactin production increases. A woman who has a large prolactinoma and becomes pregnant may experience additional pituitary growth and associated signs and symptoms, such as headaches and changes in vision.
If you have prolactinoma and you want to become or you already are pregnant, discuss the situation with your doctor because adjustments in your treatment and monitoring may be necessary.
- Prolactinoma. National Institute of Diabetes and Digestive and Kidney Diseases. http://endocrine.niddk.nih.gov/pubs/prolact/prolact.htm. Accessed Jan. 17, 2011.
- Melmed S, et al. Diagnosis and treatment of hyperprolactinemia: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2011;96:273.
- Colao A, et al. Therapy of aggressive pituitary tumors. Expert Opinion Pharmacotherapy. 2011;12:1561.
- Mann WA. Treatment for prolactinomas and hyperprolactinaemia: A lifetime approach. European Journal of Clinical Investigation. 2011;41:334.
- Klibanski A. Prolactinomas. The New England Journal of Medicine. 2010;352:121.
- Colao A, et al. Medical treatment of prolactinomas. Nature Reviews Endocrinology. 2011;7:267.
- Parlodel (prescribing information). East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2012. http://www.pharma.us.novartis.com/product/pi/pdf/parlodel.pdf. Accessed Nov. 13, 2012.
- Cycloset (prescribing information). San Diego, Calif.: VeroScience, LLC; 2010. http://www.veroscience.com/CyclosetFDAapprovedPackageInsert.htm. Accessed Nov. 13, 2012.
- Cabergoline (prescribing information). Sellersville, Pa.: Teva Pharmaceuticals; 2012. http://www.tevagenerics.com/default.aspx?pageid=3364&sortby=ProductName&ProductName=Cabergoline+Tablets&BrandName=Dostinex%C2%AE+Tablets. Accessed Nov. 13, 2012.
- Martinkova J, et al. Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas. Clinical Neuropharmacology. 2011;34:179.